RSSCategory: Science

A.I Versus M.D. – Part 2

| July 16, 2017 | 0 Comments

In April I wrote a post entitled A.I. Versus M.D. – Either Way – Pathologists Do Not Diagnose Cancer – Part 1. This was followed by a guest post by David West, CEO, Proscia, entitled AI vs MD – What it Means for Pathology in May where David, among many issues points out the use […]

Continue Reading

Cancer Center at Illinois Set to Coordinate UI’s Effort in Fight

| July 12, 2017 | 0 Comments

Congratulations to Dr. Rohit Bhargava. Dr. Bhargava is a professor in the UIUC Department of Bioengineering and a full-time faculty member in the Beckman Institute Bioimaging Science and Technology group.  Instruments developed in his laboratory have been used to provide new means to characterize and define cancer using chemical imaging that are leading to the emergence of the field of […]

Continue Reading

Will Robot Surgeons Provide Better Clinical Histories?

| July 7, 2017 | 0 Comments

Berci Mesko, MD, PhD, The Medical Futurist, a self-proclaimed “geek physician with a PhD in genomics and Amazon Top 100 author” who envisions “the impact of digital health technologies on the future of healthcare, and helps patients, doctors, government regulators and companies make it a reality” recently shared this infographic on Twitter. Berci has a lot […]

Continue Reading

Digital Pathology Association Session to Take Place at 29th European Congress of Pathology

| July 5, 2017 | 0 Comments

SAVE THE DATE! DIGITAL PATHOLOGY ASSOCIATION SESSION To take place at the 29th European Congress of Pathology Sunday, September 3, 2017 | 2:45-5:15 PM Amsterdam, The Netherlands Presentations Include: Computational Pathology and Interoperability to advance Digital Pathology Esther Abels, MSc Philips Digital Pathology Solutions   Automated IA of Immunohistochemistry as a Biomarker for Immuno-oncology Michael Montalto, PhD Bristol-Myers Squibb […]

Continue Reading

Frost & Sullivan Identifies Proscia as a Game-changing Company in Cloud-based Digital Pathology

| June 30, 2017 | 0 Comments

Proscia receives the 2017 Best Practices in Enabling Technology Leadership Award in Digital Pathology Proscia Inc., a software solutions provider for digital pathology, announced recently that Frost & Sullivan, the Growth Partnership Company, had named Proscia as the recipient of its 2017 Best Practices in Enabling Technology Leadership Award in Digital Pathology. Frost & Sullivan […]

Continue Reading

HalioDx receives CLIA Compliance for Immunoscore® Colon

| June 21, 2017 | 0 Comments

HalioDx receives CLIA Compliance for its laboratory based in Marseille Immunoscore® Colon, is now available to US patients in selected states with a turnaround time of 10 days Marseille, June 21, 2017 – HalioDx announced today that the company is compliant under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) for its Marseille-based full service […]

Continue Reading

PathPresenter.com – An Innovative Platform For Digital Pathology

| June 20, 2017 | 0 Comments

Let me describe a common scenario that plays out every week in a pathology department: You want to teach students, residents, or fellows a particular topic. You spend hours searching for cases and find some (but not enough) for a good teaching session. You know the department has a huge collection of great cases hiding […]

Continue Reading

Grail’s Billion Dollar Bet for the Perfect Cancer Test

| June 11, 2017 | 1 Comment

Thought this was worth sharing from MIT Technology Review. After attending ASCO last week what I thought might happen a year or two again actually has. Pathologists no longer have to worry about stepping out from behind the paraffin curtain as many of us were fond of saying. Tissue is not the issue anymore. At […]

Continue Reading

VisionGate Hires Dr. David Wilbur as Medical Director

| June 9, 2017 | 0 Comments

VisionGate, Inc. recently announced the appointment of Dr. David Wilbur as Medical Director of its Phoenix-based CLIA laboratory, VisionGate Biosignatures Laboratory (VBL). A world-renowned pathologist, Dr. Wilbur comes to VisionGate from Massachusetts General Hospital (MGH), where he has been a practicing pathologist since 2001. He headed the Cytopathology Unit until 2011, when he took over the […]

Continue Reading

FDA Approval of Immunotherapy For MSI-High or Mismatch Repair Deficient Tumors

| June 5, 2017 | 0 Comments

Last month the FDA approved pembrolizumab (KEYTRUDA) for adult and pediatric patients with with metastatic or unresectable, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors that have progressed following prior treatment. KEYTRUDA has also been approved fro MSI-H or dMMR colorectal cancers that have progressed following treatment with conventional chemotherapies. The immunooncology/immunotherapy story is fascinating. […]

Continue Reading

Inspirata to Participate in Thought Leadership for Cancer Information Sharing at the Association for Pathology Informatics Annual Summit in Pittsburgh May 22-25

| May 22, 2017 | 0 Comments

Inspirata will showcase its Cancer Diagnostic Cockpit and Consultation Portal as well as present scientific findings on a system that mines relevant information in cancer case reports. Pittsburgh, PA, May 22, 2017 – Cancer diagnostics and pathology workflow solution provider Inspirata®, Inc. announced today that it is exhibiting in booth B2 at the Association for […]

Continue Reading

What does FDA Approval Mean for the Digital Pathology Market? Part 1

| May 15, 2017 | 0 Comments

Much is being said, written and discussed about the recent FDA clearance for Philips digital pathology solution for primary surgical pathology diagnosis. Of course, this means an advantage for Philips right now in the market as the only FDA approved whole slide imaging system for primary diagnosis. For groups and hospitals that appreciate the two main […]

Continue Reading

ASI’s HiPath™ For Computer-Assisted PD-L1 Interpretation

| May 12, 2017 | 0 Comments

HiPath™ Supports Pathologists with Advanced Image Analysis of PD-L1 Assays CARLSBAD, CA, May 11, 2017 — Applied Spectral Imaging (ASI), a global leader of computer-assisted microscopy, introduces HiPath imaging and analysis of PD-L1 assays. PD-L1 is seen as the current breakthrough therapeutic target in immuno-oncology. Following recent clinical advances, PD-L1 expression has become a key factor in […]

Continue Reading

Visiopharm Engages in Major Initiative for Deep Learning in Tissue Based Pathology

Hørsholm, Denmark, May 3rd – Visiopharm A/S announces the first result of their multifaceted strategy to apply Deep Learning technologies to its leading image analysis solution for cancer research and diagnostics. Visiopharm considers Deep Learning an important technological breakthrough for tissue pathology that offers the potential to make a real difference in the assessment of […]

Continue Reading